Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Learn when to do a Backdoor Roth in 2026, including optimal timing around income, limits, and market conditions.
15,255 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
The Duquesne Family Office disclosed new and existing stakes in Arm Holdings, Sea Limited, and STMicroelectronics in ...
NVIDIA and Micron delivered standout AI hardware results, but investors reacted differently as the AI demand mix shif...
As deposit wars heat up in 2026, this report weighs the real value of chasing checking account bonuses worth the effo...
Meta Platforms faces a choppy start to July 2026, but a fresh meta stock price prediction points to meaningful upside...
U.S. equities rally into the holiday weekend while fuel costs ease, underscoring a split economy. This report tracks ...
Palantir’s stock has moved little over the past year despite strong revenue growth, reigniting a debate about michael...
Solana’s on-chain data show real-world asset transfers surging to $8.68 billion in the last 30 days, with asset value...
As Tesla fans cheer long-term robotaxi dreams, traders worry about delivery misses. A growing crowd is exploring inve...
Jim Cramer argues that Google could win the AI war by leveraging Apple’s massive device base, a move that could redef...
A hypothetical AI model using ChatGPT analyzes SpaceX as a public company in a volatile market, forecasting a potenti...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...